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Abstract:
Patients with end stage kidney disease (ESKD) have different options to 
replace the function of their failing kidneys. The "integrated care" model 
considers treatment pathways rather than individual RRT techniques. In 
such a paradigm, the most optimal strategy to plan and enact transitions 
between the different modalities is very relevant, but so far, only limited 
data on transitions have been published. Perspectives of patients, 
caregivers and health professionals on the process of transitioning are 
even less well documented. Available literature suggests that poor 
coordination causes significant morbidity and mortality. 
This review briefly provides background, development and scope of the 
INTErnational Group Research Assessing Transition Effects in Dialysis 
(INTEGRATED) initiative. We summarize the literature on the transition 
between different RRT modalities. Further, we present an international 
research plan to quantify the epidemiology and to assess the qualitative 
aspects of transition between different modalities. 
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Abstract: 
Patients with end stage kidney disease (ESKD) have different options to replace the 
function of their failing kidneys. The "integrated care" model considers treatment 
pathways rather than individual RRT techniques. In such a paradigm, the most optimal 
strategy to plan and enact transitions between the different modalities is very relevant, 
but so far, only limited data on transitions have been published. Perspectives of 
patients, caregivers and health professionals on the process of transitioning are even 
less well documented. Available literature suggests that poor coordination causes 
significant morbidity and mortality.  
This review briefly provides background, development and scope of the INTErnational 
Group Research Assessing Transition Effects in Dialysis (INTEGRATED) initiative. We 
summarize the literature on the transition between different RRT modalities. Further, we 
present an international research plan to quantify the epidemiology and to assess the 
qualitative aspects of transition between different modalities.  
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Introduction 
Patients with end stage kidney disease (ESKD) have different options to replace the 
function of their failing kidneys. Over the years, the search for the most optimal renal 
replacement therapy (RRT) has progressively been replaced by the understanding that 
most patients will use different modalities at different time points of their disease1-4. This 
model has been coined as "integrated care" because it intends to consider treatment 
pathways rather than individual RRT techniques2. The concept of integrated care has, 
however, been interpreted differently in different settings. In its original format, it 
involved the initiation of peritoneal dialysis (PD) followed by a timely switch to in-centre 
hemodialysis (CHD)1. In some parts of the world, this PD-first strategy was even 
implemented as a policy5-8. There is evidence to support this strategy has advantages 
both in terms of survival1,5,9-13 as for cost optimisation8,14. Progressively, it was realized 
that RRT modalities that should be made available within an integrated care program 
should not be restricted to PD and CHD, but should also include home based HD15-17, 
satellite HD, conservative care and the different modalities of transplantation. In such a 
paradigm, new questions become relevant, such as sequence and timing of different 
modalities, and the most optimal strategy to plan and enact transitions between the 
different modalities. To date, only limited data on the epidemiology of transitions have 
been published. There is also general lack of knowledge on the incidences and 
outcomes of transitions between the different modalities, and even more so of the 
underlying driving factors. Perspectives of patients, caregivers and health professionals 
on the process of transitioning are even less well documented. Available literature 
suggests that at present, transition between the different modalities is poorly 
coordinated, causing significant morbidity and mortality18.  
 
The objective of this review is to briefly provide background, development and scope of 
the INTErnational Group Research Assessing Transition Effects in Dialysis 
(INTEGRATED) initiative. We will summarize in a narrative way the present literature on 
the transition between different RRT modalities. Further, we intend to present an 
international research plan to quantify the epidemiology and to assess the qualitative 
aspects of transition between different modalities. As the transitioning between home-
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based PD to in-centre HD is one of the most frequently encountered transitions, we will 
use this transition as a template to describe the methodology that will also be used to 
analyse the other transitions possible between the different RRT modalities. The group 
decided not to elaborate in first line on the start of renal replacement therapy, the most 
frequent transition as it was judged that already plenty data on this transition have been 
accumulated over the last decade, and that therefore, further research on this topic was 
not a priority.19,20.  
 
 
Background, aims and scope of the INTEGRATED initiative 
Based on personal initiative, and supported by an unrestricted research grant (Baxter 
Global Grant Progam), the INTEGRATED initiative group was established to set up 
international research on aspects of transitioning between the different RRT modalities. 
This initiative was founded in response to a shared perception that there were big gaps 
in knowledge and data on this important part of RRT care.  
The core group convened in Paris to define the scope and the relevant topics to be 
explored within this initiative. Participants (see supplementary document) were each 
asked to prepare 3 questions they considered as most relevant with regard to 
transitioning, and send them before the meeting to the coordinating team. These 
questions were pooled and duplicates removed (table 1).  
During different chaired group sessions using a modified nominal group technique, 
different themes for research were distilled from these proposed questions:  
a/ barriers/facilitators to successful transition;  
b/ understanding of  integrated care flow path;  
c/ optimizing outcomes of transitions;  
d/ impact of planned vs unplanned transitions;  
e/ experiences, perceptions and beliefs of patients and healthcare workers on 
transitioning. 
Building on these themes, the INTEGRATED group considered that there was a need to 
create two different work streams to better understand transitioning, and to support 
development of strategies to improve outcomes. First, there was a perceived need for 
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quantitative methodology to explore the epidemiology of transitions by mining national 
and international registries to gain insight into the outcomes and associated factors of 
transitioning. Second, using qualitative methodology, to explore the perspectives of 
patients, relatives and health care professionals was deemed to be of high importance 
to improve understanding of the needs, facilitators and barriers to successful transition, 
and to determine outcomes that could be used to evaluate success of transitioning 
programs. It was appreciated that for some topics, a mixed methods approach would be 
most suited. Last, it was correctly suggested during the process that it would be very 
appropriate and useful to include the patient voice also in steering the research 
questions. Patient representation in the INTEGRATED group, either through individual 
patients, or through organisations representing patients, will be actively explored. 
  
Page 6 of 26Peritoneal Dialysis International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
6 
 
Quantitative analysis: Background and Rationale  
As stated above, the INTEGRATED group elected to first explore the epidemiology, 
predictors and outcomes of transition from PD to in-center HD. This specific transition 
was targeted, as this is one of the most common transitional periods during RRT. Yet, 
little quantitative data are available on the transitioning from PD to CHD with regards to 
incidence, driving factors, risk factors, and especially outcomes in terms of mortality and 
morbidity. Overall, technique failure is a universal reality of PD and its high attrition rate 
translates into the globally low prevalence of PD internationally 21. In many countries, 
less than 50% of patients will have remained on PD two to three years after PD 
initiation, with a high proportion being transferred to HD 22-29.  
There appear to be two stages in the PD to CHD transition: one early in the first three to 
six months after the start of PD, and one later on23,24,26,30,31. Risk factors may vary 
according to the length of PD duration with, for instance, higher involvement of catheter-
related dysfunction in the early period transition24,31. In a US cohort, 22% of incident 
patients transitioned to CHD within the first 3 months, the majority of them on a central 
venous catheter32. Several patient-related factors such as gender, race, body mass 
index, diabetes, social deprivation, number of peritonitis episodes, education level and 
PD catheter dysfunction have been associated with higher risk of PD technique failure 
23,24,33-37.  Nonetheless, these factors poorly correlate with the large variability of 
technique failure across different centres and countries and centre-related 
characteristics such as centre size, proportion of patients treated with PD and centre 
compliance with phosphate targets are emerging as important predictors of PD 
technique failure hazard 22,38-41.  
Moreover, the scant available data on PD to CHD transition teach important lessons, 
and seem to challenge some existing prejudices. For example, a recent analysis of 
United States Renal Data Systems (USRDS) data regarding the evolution of the 
incidence of transitioning from PD to CHD over the years seems to contradict the 
assertion that a higher PD incidence will result in more technique failure (Sukul and al. 
unpublished data). Indeed, whereas the PD to CHD transition rate remained stable, 
mortality decreased over the years, supporting the notion that expanding PD programs 
can improve outcomes. A similar finding was found in a Canadian study with a decrease 
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in mortality but mostly stable risk of technique failure throughout the years 27. In 
contrast, other studies have shown an improvement in technique failure in recent 
compared to earlier PD cohorts41-43  
Couchoud et al44 developed a mathematical model based on data from the Renal 
Epidemiology and Information Network (REIN) registry to improve understanding of the 
complexity of the RRT modality landscape. This model can help policy makers to 
estimate effects at society level to stimulate or not certain RRT options44.  
While predictors of PD technique failure and transition to HD have been assessed in a 
number of studies, quality data on the clinical outcomes following transfer from PD to in-
centre HD are still scarce. This is different from the HD-to-PD transition, where transfer 
to PD was associated with an increased risk of death and technique failure1,45-47. In a 
retrospective single centre study, the switch to hemodialysis did not adversely affect 
patient outcomes provided the patients survived the first 60 days.29 However, exclusion 
of events during this first 60 days limits the relevance of this study, as it is potentially the 
highest risk period for patients transitioning between dialysis modalities 19. A Spanish 
study reported that patients who started on PD with subsequent transfer to HD had a 
higher crude survival than those who started on HD, although no adjustment for 
confounding was performed48. A single-center US study reported a 6-month and 12-
month survival of 92% and 85%, respectively, in a cohort of 120 patients49.  
In an Australia and New Zealand study including 4781 incident PD patients, those 
transferred to HD with a central venous catheter (CVC) at transfer had a higher mortality 
than patients initiated on HD with an arteriovenous fistula or graft26. In a French 
multicenter study evaluating 60 PD patients with a transfer to HD, unplanned transition 
was a risk factor for hospitalization at time of transition18. Temporary or permanent 
transfer to HD was not associated with a significant difference in survival in Australian 
PD patients with peritonitis50. Finally, an ANZDATA study showed that patients 
transferred from PD to home HD had a similar survival than those directly initiated on 
HHD15. Overall, most studies evaluating the outcomes of transition between PD and in-
centre HD are of limited quality because of single-centre design, lack of adjustment for 
significant variables and poor generalizability of the results.  
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Quantitative Analysis: collaboration among international registries 
As indicated above, a key component of this INTEGRATED initiative is the close 
collaboration among investigators from various international registries to: (1) help 
facilitate analyses to be carried out in a nearly identical fashion by each registry, and (2) 
describe overall rates and outcomes across participating registries, and how these vary 
across registries. This international collaboration also serves as a means to foster 
different perspectives and broader considerations in framing INTEGRATED analyses 
than may occur from only one registry with the goal of study findings to be pertinent for 
addressing key issues relevant to different international perspectives. 
Currently, the registries which have closely collaborated in developing the quantitative 
INTEGRATED study include the Australian and New Zealand Dialysis and Transplant 
(ANZDATA) Registry (www.anzdata.org.au), United States Renal Data System 
(USRDS; www.usrds.org), Canadian Organ Replacement Register (CORR; 
www.cihi.ca/en/canadian-organ-replacement-register), and the European Renal 
Association – European Dialysis and Transplant Association (ERA-EDTA)_Registry 
(www.era-edta-reg.org) consisting of 31 registries from 17 European countries. Data 
from the international Dialysis Outcomes and Practice Patterns Study (DOPPS) 
Program are also being planned for use in future INTEGRATED investigations, and with 
the ability to collect specific new data that may not be collected by registries if helpful for 
future INTEGRATED studies. Sharing of analytic research plans and sharing of 
programming code (as needed by registry participants) have greatly aided the goal of 
utilizing the same definitions for study outcomes, predictors, and other key variables, 
what inclusion and exclusion criteria are used in defining the study cohort within each 
registry,  and for carrying out analyses in a similar fashion by each registry.  
This first phase of the INTEGRATED initiative has been limited thus far to the above 
registries as a means to work out and harmonize the processes of carrying out such a 
large international collaboration and demonstrate the ability to be successful in this 
endeavour. However, one goal of INTEGRATED is to ultimately have even broader 
international involvement once success has been demonstrated in these initial two 
projects since the findings from other registries will be very important and provide 
valuable perspectives regarding the outcomes pertinent to this INTEGRATED 
Page 9 of 26 Peritoneal Dialysis International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
9 
 
initiative51. Other research groups and registries are invited to contact us and join 
INTEGRATED. 
 
Quantitative Analysis: research proposal  
Given that more than 1/3 of patients will experience a transition to another RRT 
modality, particularly to facility-based conventional haemodialysis (CHD)25,27-29,42,52, 
within the first 3 years on PD, a better understanding of morbidity and mortality 
associated with this transition is critically important for the care of patients with end-
stage kidney disease (ESKD).  
As underlying modifying factors might be related to geographical or organisational 
factors, an international approach to the analysis is warranted. The INTEGRATED 
initiative postulates that the period (weeks before to months after) around transitioning 
between RRT modalities is associated with heightened risk of morbidity (including 
impaired quality of life) and mortality as compared with other time points in the RRT 
journey. This risk then gradually decreases to reach the baseline rate of the new 
modality. This ‘maximal risk period’ will differ for each type of RRT transition (e.g. PD to 
HD versus transplant to PD). Determining this risk evolution over time is essential to 
benchmark transition success. We further postulate that specific patient, centre and 
state/country-related factors are associated with successful vs unsuccessful RRT 
transitioning. Knowing these specific risk factors is essential to adjust for underlying 
differences in case-mix and to allow benchmarking between centres/regions. 
Furthermore, knowledge of these underlying factors might reveal modifiable risk factors, 
thereby allowing improvement of the process of care and thus outcomes.  
 
To test these hypotheses, the INTEGRATED initiative will leverage available renal 
registries (USRDS, CORR, ANZDATA, DOPPS and ERA-EDTA registry and others 
willing to join in the future) with the following specific aims:   
A. To identify the incidence, predictors, risk factors, and outcomes of transitions 
between PD to CHD.  
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B. To compare crude and adjusted death rates, morbidities and risk factors in the 
early (<3, <6 months) and late (> 6 months) period following a transition from PD 
to CHD. 
C. To analyse on a worldwide/regional basis which parts of the renal replacement 
portfolio are actually made available to patients at the centre level. This is an 
important question, as availability of different modalities is a prerequisite for free 
patient choice and for timely and appropriate transition. The question will be 
explored by a systematic analysis at country/regional level of how care is organised 
at centre level. 
 
A statistical analysis plan has been agreed between the registries participating in the 
INTEGRATED research collaborative.  
The first major challenge was to agree on what exactly constituted a transition from PD 
to CHD. Whilst most registries do not have a specific definition for transition53, it was 
agreed within the INTEGRATED initiative that transfer from PD to CHD for a period of 
30 consecutive days or longer would constitute a transition, as per the standardized 
definition proposed by the ANZDATA Registry54. Similar reasoning will be used later on 
for transitions between other RRT modalities. Sensitivity analyses will also be 
performed using alternative definitions of 60, 90 and 180 days. 
Studies will include all patients with ESKD who commenced RRT between 1 January 
2000 and 31 December 2014, and initiated PD for at least 1 day within 180 days of RRT 
commencement. The rate of first transition from PD to CHD will be expressed as 
number per 100 patient-years and the patient- and centre-level characteristics 
associated with transition will be evaluated using a Cox proportional hazards with 
shared frailty model. Patient-level characteristics will include age, gender, race, body 
mass index, smoking status, diabetes, cardiovascular disease, peripheral vascular 
disease, cerebrovascular disease, initial PD modality and initial RRT modality. Centre-
level characteristics will, as a minimum, include centre size (calculated as mean number 
of incident PD patients at the centre), PD proportion (proportion of all dialysis patients at 
centre treated with PD), automated PD (APD) versus CAPD use (proportion of centre 
PD patients exposed to APD at least once), transplant centre status (defined as whether 
Page 11 of 26 Peritoneal Dialysis International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
11 
 
or not at least one kidney transplant was performed in the same hospital as the PD 
centre) and type of centre (public/private/University/urban/rural/remote)55. PD 
commencement era will also be included as a fixed effect covariate in the final model to 
adjust for era effect. Results will be presented for countries and regions to ascertain 
potential regional variability. For Japan, a separate analysis for patients transitioning 
from PD to hybrid PD/HD combination could be considered. 
 
The primary outcome of the quantitative analysis will be mortality following transition. 
Time from PD->CHD transition to all-cause mortality will be assessed using a Cox 
proportional hazards model with multi-level, mixed effects analyses being performed to 
take into account data clustering on dialysis centre and/or region/country. Data will be 
censored at the time of transplantation, any subsequent RRT transition, recovery of 
renal function or the end of follow-up. Competing risks analyses will also be undertaken. 
Mortality rate will further be evaluated in a count model at different time points after 
transition, presented as weekly (1-7, 8-14, 15-21, 22-28 days, etc.) or monthly (30, 60, 
90 days, etc.) mortality rates. 
Sensitivity analyses will be undertaken, including: 1) with and without censoring the 
follow-up at time of a subsequent modality change and/or transplantation; 2) with 
restriction of the cohort to patients without hospitalization at the time of transition (as a 
marker of an acute medical event); and, 3) including only the first RRT transition during 
the RRT journey (i.e. only 1 transition per patient allowed), 4) a planned subgroup 
analysis in a cohort of patients who, at start of RRT, have a predicted survival of more 
than 5 years. This specific patient group is most likely to undergo a transition, and the 
impact of transition (positive and negative) is therefore likely to be higher in this specific 
subgroup than in patients with an intrinsically limited life expectancy.  
 Secondary outcomes will include cause-specific mortality (cardiovascular, infectious, 
dialysis withdrawal, etc.), hospitalization, and predictors of successful transition (i.e. 
being alive 30 days after transition). 
 
We will also describe the proportion of PD patients who undergo a transition to in-centre 
HD within a given year as well as switches to all of the following outcomes: 
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- Death/withdrawal from dialysis without transfer to CHD 
- Death/withdrawal from dialysis after having switched to CHD for <30 days 
- Transition to transplant 
- Transition to home hemodialysis (defined as home HD for >30 consecutive days) 
- Recovery of kidney function or loss-to-follow-up (which is quite low) 
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Qualitative approach: general considerations of "change processes":  
 
Transitioning from one therapy to another can be seen as a specific application of the 
change process occurring in the business world. Change is a gradual process, with well 
defined, distinct steps all with their specific properties, opportunities and pitfalls. 
Typically, the different steps can be distinguished as current situation, the letting go 
stage (grieving), the new beginning stage and the new situation. The nature, 
appreciation and perception of these different phases will impact on the final result and 
acceptance of the new situation (figure 2). For example, it could be hypothesized that a 
patient who is doing very well on PD, but needs to transfer to in-centre HD because of a 
perforated diverticulitis, will not have had very much opportunity to reflect on the 
prospect of leaving PD and starting HD, and will therefore perceive this transition as a 
"loss", whereas a patient who is on PD for many years, with an increasingly complex 
regimen due to decreasing residual renal function, will potentially see a transfer to HD 
as a relief from a burden. It can thus be hypothesized that a better understanding of the 
emotions and perceptions of the patient in this context can help the health care provider 
to support the patient in a more tailored way, which will result in an improved outcome. 
In general, a successful change will require that there is an awareness of the need to 
change, a tendency to support the change, sufficient knowledge on what the change will 
look like, and the willingness and capacity to implement the change. Applied to renal 
replacement therapies, this implies that patients should be made aware from the 
beginning that a transfer might be needed at some point, what can be underlying 
reasons/motivations to do so, and what are the alternative options: in short, patients 
should be informed from the start, and empowered to sustain the transition. Sufficient 
health care professionals with suitable competences should be made available to 
support the patients in the transitioning process. Most people have an inherent 
tendency to object to change. This can reveal itself as an inclination to try to block off or 
deny the change (passive objection), or by blaming others for the incurred problems or 
even by aggressive behaviour (active objection). Such aggressive behaviour can be 
directed towards family and carers, to health care professionals, but also to the disease 
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or the patient him/herself. It is important to recognize and clarify this feeling of revolt to 
avoid escalation and conflict. 
More positive coping strategies are to explore the advantages of the new situation, and 
how eventual problems can be turned into opportunities. In most situations, it is 
important to avoid framing the new situation as good by framing the old situation as bad 
or poor. Most patients will indeed have felt comfortable with the old situation, and 
presenting it as poor might damage credibility and thrust. Emotions underlying this 
objection or resistance to change are loss of control, uncertainty over the future, 
surprise, perception of failure, fear to fail in the new situation, and the fear that this 
change might be just a first step in a downward cascade. In the case of transitioning 
between different renal replacement modalities, the current change might often dredge 
up previous experiences of the disease process. Again, it is of importance to present 
already early on that transition is part of a (planned) process.  
  
Qualitative analysis: what is already known on transitioning in renal replacement 
therapy 
There are little or no data on qualitative evaluations of transitioning between the 
different RRT modalities. A Pubmed search using combinations of MeSH terms 
"qualitative research", "peritoneal" dialysis", "treatment failure" yielded 131papers, but 
only two of those directly or indirectly related to transitioning between home-based 
therapies and centre-based renal replacement therapies. In a qualitative analysis of 
modality selection for home-based therapies, different themes were identified56. 
Optimizing survival was one of the considerations when making a modality choice. 
Consequently, it can be expected that providing evidence to the patient that a 
transitioning will not jeopardize outcomes, or might even at that specific time point 
improve survival, will be determinant for how patients perceive the transitioning process. 
In this regard, the work of the quantitative part of INTEGRATED is essential. Sustaining 
relationships and minimizing lifestyle disruption were also identified as important themes 
in modality selection for home-based therapies. It can be expected that a transfer to a 
centre-based treatment modality will have a negative impact on these aspects, and will 
accordingly contribute to a negative perception of the patient and caregivers. Lacking 
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decisional power was an element that favoured a choice for centre-based therapies. 
Accordingly, it can be expected that patients who initially opt for a home-based 
treatment tend to be more independent and prefer to make their own choices. Not 
having a choice, for example, because of a medical contra-indication to continue the 
home-based treatment, might have a strong negative impact for these patients.  
Life participation seems to be superior for patients with a kidney transplant vs dialysis, 
but apparently, there are few differences between patients on hemodialysis and 
peritoneal dialysis. These results were consistent throughout study periods, across 
diverse populations, and among the subset of studies that performed appropriate 
adjustments for potential confounding factors57. However, these were all cross-sectional 
studies, and there might thus be bias by indication. It can therefore not be automatically 
derived that a transitioning from PD to CHD will not impact on the perceived life 
participation, especially when this transitioning is abrupt or forced (lack of choice). In 
that regard, it will be of interest to compare experiences, feelings and attitudes of 
patients immediately after transitioning as compared to after some months on the new 
modality. If there is truly no difference in life participation between PD and CHD, it can 
be hypothesized that once people accommodate to CHD, their perception of life 
participation will go up again to what it was before the transitioning 
(accommodation/adaptation).  
 
Qualitative approach: proposal for qualitative research on transitioning 
Transitioning from one modality to another can have an enormous impact on the well-
being and lifestyle of patients and their caregivers. Little is known regarding what factors 
make patients’ transition and their caregivers experiences successful, stressful or even 
unsuccessful. Moreover, data are lacking on how patients and their caregivers perceive 
such a transition, what their ideas and emotions are, and how they cope with them. 
Furthermore, transitioning can also have an impact on the health care professionals 
involved in this process, whereas at the same time, a variety of emotions, perceptions, 
motivations and beliefs of health care professionals might drive, delay or impede 
transitioning, leading to patients not receiving the treatment that best suits their needs at 
a given moment.  It has so far not been explored which mechanisms drive the emotions, 
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perceptions and eventually behaviours of patients and health care workers in relation to 
the transitioning. Understanding these mechanisms is a first essential and important 
step to improve care processes in this regard.  
It can be hypothesized that, besides the medical outcome of the transition itself, other 
factors will influence whether patients experience their transition as successful or not. 
Understanding these associated factors and the emotions, perceptions and 
mechanisms linked to them might also be relevant to improve the approach and 
management of transitioning. Therefore, the qualitative part of the INTEGRATED 
project intends to explore and analyse patients', caregivers’ and health professionals’ 
perspectives and experiences and the underlying mechanisms thereof of transitions 
between the different renal replacement therapy modalities.  
 
We will first focus on the transition from self-managed (home based) to healthcare 
worker managed (centre-based) treatments. At a later stage, we will also explore 
transitions from failed transplant back to RRT. We hypothesize that this qualitative 
research might help to understand and explore options for how clinical practice might 
need to change so that patients’ and caregivers’ experiences of transition are optimised.  
 
We will use different strategies: 
1/ Qualitative semi-structured interviews of patients who actually went through a 
transition. We are interested to know experiences and perceptions of aspects related to 
the transitioning process, and what these mean to patients and their caregivers. We 
also intend to find out how patients and their caregivers cope with this transitioning, and 
how renal units can support them through it. We hypothesize that finding out which 
factors made this transition to be perceived as successful or not should help renal units 
to improve care to patients and provide better support when treatments might need to 
be changed. Next to open questions, we will also specifically explore themes associated 
with change in treatment reported in the literature if they were not brought up 
spontaneously as a theme by the patient him/herself: the role and timing of information, 
the prediction of need for transition and discussion of alternative options, the role of 
exposure to peers and the impact of social support.  
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We will use a purposive sampling aiming at an equal distribution of patients with 
medically successful and unsuccessful transitions, from different socio-economic 
backgrounds, age and gender. Patients will be included until saturation. Patients will be 
selected from different regions (Belgium, UK, Canada and Australia). Transcripts of 
individual interviews will be checked for accuracy and imported into a qualitative data 
management program to facilitate data management. Textual data from the interview 
transcripts will be analysed inductively, using an interpretive approach of qualitative 
description. Transcripts will be coded for emergent themes and patterns, and constant 
comparison will be employed in order to identify similarities and differences within and 
across patients. 
We will not use surveys of established instruments such as SF-36 or others, or patient 
activation measure (PAM), as these do not provide additional insights in the underlying 
processes. 
 2/ Qualitative structured interviews of health care professionals to explore which factors 
they believe make a transition successful or not.  Preferentially, healthcare workers from 
different backgrounds and settings will be interviewed. 
3/ Systematic literature review on 1 and 2 to identify issues, themes, topics and 
constructs that can be used during the interviews.  
4/ Focus groups with patients who underwent a transition, patients who did not (yet) 
undergo a transition, and with healthcare professionals (nephrologists, nurses) to 
explore factors and their importance for a transition being called successful or not. 
5/ Identification, prioritisation, and gaining of consensus on non-medical outcomes that 
are of importance for evaluating successful transition between dialysis modalities and 
the reasons for these priorities. An online Delphi approach will be used to select these 
non-medical outcomes for benchmarking. Patients, caregivers and health professionals 
will be invited to complete two rounds of the Delphi survey to reach consensus about 
priorities. As a list of potential outcomes will have already been generated from other 
phases of the INTEGRATED initiative, only two rounds will be required rather than the 
usual 3 rounds, whereby the first round is used to generate outcomes for use in rounds 
2 and 3.  
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By the end of the project, a rich picture will have been developed of the range of 
perspectives and experiences of patients and caregivers going through treatment 
modality transitions. The project will also be able to demonstrate how this information 
can be used to develop a shared understanding amongst patients, caregivers and 
health professionals about how clinical practice might need to change to improve 
outcomes. We will also have achieved a consensus about the selection of outcomes 
which could be used in future studies to evaluate interventions designed to improve the 
experience of transitions, and will have a clear understanding about the rationale for 
selecting these outcomes.  
 
Summary and conclusions 
The INTEGRATED initiative is an international research collaborative that seeks to 
explore existing data and generate new data on the transitioning of patients between 
different renal replacement therapies. INTEGRATED is an open collaborative effort, so 
people willing to do so can join, provided they are willing to share efforts and data. 
Please contact us by mail in that case. 
We will explore and generate both quantitative as qualitative data to better understand 
the process, with the intention to apply this knowledge to steer practice and improve 
outcomes of patients during their journey with end stage renal disease. 
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Figure 1: Scoping the themes and questions of the INTEGRATED initiative 
 
 
 
 
Figure 2: Factors influencing perception and acceptance of a change process 
Pooled Primary (pre- meeting ) questions
* Selection criteria/ Medical indications for transitioning
* Psychosocial barriers
* What is the optimal duration of PD therapy?
* Should dialysis be started with PD (PD first)? 
* Does PD first followed by h me HD improve outcomes
* What are the predictors of successful transition
* What are the outcomes after transitioning (mortality, morbidity, quality 
of life), immediate and longer term
* What are the reasons/motivations for transitioning (medical, non-
medical) 
* impact of planned vs unplanned transitioning 
* impact of positive vs negative choice?
* How many centers organize planned transitioning?
* Risks factors predicting transitioning? 
* Risk factors associated with positive/negative outcome of 
transitioning
* How to improve outcomes of transitioning
* How do transitions affect costs/cost effectiveness of RRT?  
* Does an optimal RRT flow chart exist (universal vs individual)? 
* Are patients informed about potential future transitioning? 
* Perceptions of health care professionals on transitioning? 
* Place of transplantation modalities? Themes 
* Planned vs unplanned transitioning 
* Timing of transitioning
* Selection criteria/indications for transitioning
*I ntegrated care flowcharts
* Optimization of transitioning/ Barriers/ facilitators
* Patient and health professional’s perception, beliefs, 
experiences on transitioning
Quantitative analysis: epidemiology 
Qualitative analysis: patient and health care 
professionals perceptions, experiences, beliefs
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Transition
process
Time:
how
quickly/abrupt 
is the change?
Scope: 
which aspects
of the 
treatment need
to be changed?
Readiness: 
has the patient
been prepared for 
the transition
Power: 
who or what
drives the need
to change
Capacity: 
are resources 
available to make
the transition
successfull,
Capability: is
there experience
and willingness in 
the team to 
support the 
transition? 
Diversity:  will
the transition
involve a new
health care 
team,or hospital? 
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